Corrigendum to: “Co-delivery of methotrexate and berberine based on PAMAM dendrimers for targeting HeLa cancer cells” [Toxicol. Rep. Volume 13, December 2024, 101765] (Toxicology Reports (2024) 13, (S2214750024001483), (10.1016/j.toxrep.2024.101765))

  • Hossein Majidzadeh
  • , Mostafa Araj-Khodaei
  • , Ayuob Aghanejad
  • , Maryam Ghaffari
  • , Amir Jafari
  • , Forough Jenanifard
  • , Jafar Ezzati Nazhad Dolatabadi
  • , Hashem Andishmand
  • , Michael R. Hamblin

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Corrigendum to: “Co-delivery of methotrexate and berberine based on PAMAM dendrimers for targeting HeLa cancer cells” [Toxicol. Rep. Volume 13, December 2024, 101765] (Toxicology Reports (2024) 13, (S2214750024001483), (10.1016/j.toxrep.2024.101765))'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases